Emergency Medicine Reports - December 26, 2004

Target Audience:

This activity is intended for the emergency physician.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Authors
Larissa I. Velez, MD
Assistant Professor
Assistant Director of Emergency Medicine Residency Program
University of Texas Southwestern Medical Center
Dallas

Wilfredo Rivera, MD
Assistant Professor
Emergency Medicine
University of Texas Southwestern Medical Center
Dallas;
Associate Medical Director
North Texas Poison Center

John Marcucci, MD
Clinical Instructor
Emergency Medicine
University of Texas Southwestern Medical Center
Dallas
Medical Director
Emergency Department
Baylor Regional Medical Center
Plano, TX

Fernando Benitez, MD
Assistant Professor
Emergency Medicine
University of Texas Southwestern Medical Center
Dallas

Peer Reviewers
Sandra M. Schneider, MD, FACEP
Professor and Chair
Department of Emergency Medicine
University of Rochester School of Medicine
Rochester, NY

Gregory A. Volturo, MD, FACEP
Associate Professor of Emergency Medicine and Medicine
Vice-Chairman
Department of Emergency Medicine
University of Massachusetts Medical School
Worcester, MA

Editor-In-Chief
Gideon Bosker, MD
Special Clinical Projects and Medical
Education Resources
Assistant Clinical Professor
Section of Emergency Services
Yale University School of Medicine
Associate Clinical Professor
Oregon Health Sciences University

Subjects:

  • Dealing with Drug-Seeking Patients in the Emergency Department

Objectives:

  • Quickly recognize or increase index of suspicion for specific conditions
  • Understand the epidemiology, etiology, pathophysiology, and clinical features of the entity discussed
  • Perform necessary diagnostic studies correctly
  • Take a meaningful patient history that will reveal the most important details about the particular medical problem discussed
  • Apply state-of-the-art therapeutic techniques (including the implications of pharmaceutical therapy discussed) to patients with the particular medical problems discussed
  • Have an understanding of the differential diagnosis of the entity discussed
  • Understand both likely and rare complications that may occur
  • Provide patients with any necessary discharge instructions

Financial Disclosure:

To reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, we disclose that Larissa I. Velez, MD, Wilfredo Rivera, MD, John Marcucci, MD, Fernando Benitez, MD (authors), Sandra Schneider, MD, FACEP, and Gregory A. Volturo, MD, FACEP (peer reviewers) report no relationships with companies related to the field of study covered by this CME program. Gideon Bosker, MD, FACEP (editor) is on the speaker’s bureau for Pfizer, Sanofi-Synthelabo, Bristol-Myers Squibb, Roche Pharmaceuticals, and Schering Plough Corp. Dr. Bosker also acknowledges that he receives royalties, commissions, and other compensation relating to the sale of textbooks, reprints of articles, and other written materials to the following pharmaceutical companies: Pfizer, Genentech, Aventis, Pharmacia, and Bayer.

Copyright 2005 AHC Media. All rights reserved.